Nanotechnology and pancreatic cancer management: State of the art and further perspectives
Authors:
- Damiano CaputoDamiano Caputo
- Daniela PozziDPDaniela Pozzi
- Tommaso FarolfiTFTommaso Farolfi
- Roberto PassaRPRoberto Passa
- Roberto CoppolaRCRoberto Coppola
- Giulio CaraccioloGCGiulio Caracciolo
Open Access
- 15 April 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 13 (4) , 231-237
Abstract
Nanotechnology and pancreatic cancer management: State of the art and further perspectivesKeywords
This publication has 27 references indexed in Scilit:
- The dark side of immunotherapy: pancreatic cancerCancer Drug Resistance, 2020
- Proteomic biomarkers in body fluids associated with pancreatic cancerOncotarget, 2018
- A guide to aid the selection of diagnostic testsBulletin of the World Health Organization, 2017
- Pancreatic Ductal Adenocarcinoma: Current and Evolving TherapiesInternational Journal of Molecular Sciences, 2017
- Advances in pancreatic cancer research: Moving towards early detectionWorld Journal of Gastroenterology, 2014
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNature Nanotechnology, 2013
- Biomolecular coronas provide the biological identity of nanosized materialsNature Nanotechnology, 2012
- Understanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChemical Society Reviews, 2011
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal CancerJournal of Clinical Oncology, 2006
- Pancreatic cancerCurrent Problems in Cancer, 2002